. The significance of serum sST2 and cfDNA in children with severe pneumonia complicated by myocardial damage
serum sST2 and cfDNA in children with severe pneumonia complicated by myocardial damage
Abstract
Objective: The paper aimed to explore the significance of serum sST2 and cfDNA to prevent atrial inflammation in children with severe pneumonia complicated by myocardial damage. Methods: 120 children with severe pneumonia complicated by myocardial damage who were treated in the Children's Department of the author's hospital from April 2021 to December 2023 were recruited as research subjects. The children were randomly divided into two groups, one group of 60 children received personalized care intervention based on serum sST2 and cfDNA (personalized care group), and the other group of 60 children received routine care (routine care group). The clinical data of the two groups of patients were compared. The changes in serum sST2 and cfDNA levels of patients were compared before and after care. ELISA kits were used to test atrial inflammation marker levels before and after patient care. The patient's cardiac function was assessed through cardiac ultrasound. the nursing intervention effects of the two groups was compared. The patient satisfaction with nursing care was compared between the two groups. Results: There was no distinction in the general record of the two groups (P>0.05). Before care, there was no distinction in serum sST2 and cfDNA levels between the two groups (P>0.05). After care, the serum sST2 and cfDNA levels in the personalized care group were lower than those in the routine care group (P<0.05). There was no difference in CRP, cTn, 1L-6 and TNF-α between the two groups before nursing (P>0.05). After nursing, the levels of CRP, cTn, 1L-6 and TNF-α in personalized nursing were lower than those in the conventional nursing group (P<0.05). Parameters such as EF and E/A in the personalized care group were higher than those in the routine care group (P<0.05). The LVEDd and LVESd in the personalized care group were smaller than routine care group (P<0.05). The improvement rate of cardiac function, remission rate of atrial inflammation and 6-month re-hospitalization rate in the personalized care group were lower than conventional care group (P<0.05). The very satisfied rate in the personalized care group was higher than routine care group (P<0.05), and the dissatisfaction rate in the personalized care group was lower than routine care group (P<0.05). Conclusion: Personalized nursing intervention based on serum sST2 and cfDNA can significantly improve the cardiac function of children with severe pneumonia complicated by myocardial damage, reduce the levels of atrial inflammation markers, and advance the satisfaction of children and their families. These findings underscore the importance of applying serum sST2 and cfDNA monitoring in clinical care and the significant benefits of personalized care in preventing atrial inflammation, improving heart health, and improving patient quality of life.
References
[1] Lopes LA, Agrawal DK. Post-Operative Atrial Fibrillation: Current Treatments and Etiologies for a Persistent Surgical Complication[J]. J Surg Res (Houst), 2022, 5:159-172.
[2] Castiglione V, Aimo A, Vergaro G, et al. Biomarkers for the diagnosis and man-agement of heart failure[J]. Heart Fail Rev, 2022, 27:625-643.
[3] Samura B, Panasenko M. SST2 AS A PREDICTOR OF STATIN TREATMENT EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA[J]. Georgian Med News, 2022:18-22.
[4] Di Biase L, Marazzato J, Zou F, et al. Point-by-Point Pulsed Field Ablation Using a Multimodality Generator and a Contact Force-Sensing Ablation Catheter: Compar-ison With Radiofrequency Ablation in a Remapped Chronic Swine Heart[J]. Circ Ar-rhythm Electrophysiol, 2023, 16:663-671.
[5] Hiram R. Resolution-promoting autacoids demonstrate promising cardioprotec-tive effects against heart diseases[J]. Mol Biol Rep, 2022, 49:5179-5197.
[6] Nasiri M, Jafari Z, Rakhshan M, et al. Application of Orem's theory-based caring programs among chronically ill adults: A systematic review and dose-response meta-analysis[J]. Int Nurs Rev, 2023, 70:59-77.
[7] Kramer MR, Schmiesing L, von Dach C. Illuminating Nursing's Value: The 12 Anthroposophic Nursing Gestures[J]. J Holist Nurs, 2022, 40:281-294.
[8] Figuracion KCF, Thompson H, Mac Donald CL. Integrating Neuroimaging Measures in Nursing Research[J]. Biol Res Nurs, 2023, 25:341-352.
[9] Arnaud C, Billoir E, de Melo Junior AF, et al. Chronic intermittent hypoxia-induced cardiovascular and renal dysfunction: from adaptation to maladaptation[J]. J Physiol, 2023, 601:5553-5577.
[10] Khatib M, Elbaz-Greener G, Nitzan O, et al. Unmasking Myocardial Dysfunc-tion in Patients Hospitalized for Community-Acquired Pneumonia Using a 4-Chamber 3-Dimensional Volume/Strain Analysis[J]. J Digit Imaging, 2022, 35:1654-1661.
[11] Meng L, Peters MDJ, Sharplin G, et al. Outcome measures of palliative care programs and interventions implemented in nursing homes: a scoping review proto-col[J]. JBI Evid Synth, 2022, 20:715-722.
[12] Papadimitriou MA, Levis P, Kotronopoulos G, et al. Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome[J]. Clin Chem, 2023, 69:399-410.
[13] McDermott-Levy R, Mariani B, Lupinacci P. Nursing Students' Self-Efficacy in Immigrant Health[J]. Nurse Educ, 2022, 47:225-229.
[14] Witkowska A, Staciwa M, Duraj I, et al. Interleukin-33/sST2: Dynamic assess-ment in patients with acute coronary syndrome[J]. Adv Med Sci, 2023, 68:195-201.
[15] Curtis AC, Keeler C. Diagnostic Studies: Measures of Accuracy in Nursing Re-search[J]. Am J Nurs, 2022, 122:44-49.
[16] Schrag D, Beer TM, McDonnell CH, 3rd, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study[J]. Lancet, 2023, 402:1251-1260.
[17] Gao Q, Lin YP, Li BS, et al. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies[J]. Ann Oncol, 2023, 34:486-495.
[18] Pantazi D, Tselepis AD. Cardiovascular toxic effects of antitumor agents: Patho-genetic mechanisms[J]. Thromb Res, 2022, 213 Suppl 1:S95-s102.
[19] Wernly S, Paar V, Völkerer A, et al. sST2 Levels Show No Association with Hel-icobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Re-search[J]. Dig Dis Sci, 2023, 68:3293-3299.
[20] Yan W, Feng Y, Lei Z, et al. MicroRNA-214-3p Ameliorates LPS-Induced Car-diomyocyte Injury by Inhibiting Cathepsin B[J]. Folia Biol (Praha), 2022, 68:78-85.
[21] Buffolo F, Tetti M, Mulatero P, et al. Aldosterone as a Mediator of Cardiovascu-lar Damage[J]. Hypertension, 2022, 79:1899-1911.
[22] Pintz C, Briggs L, Zhou QP, et al. Hospital-Based Nursing Research: Clinical and Economic Outcomes[J]. West J Nurs Res, 2022, 44:356-366.
[23] Wang S, Meng F, Li M, et al. Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer[J]. Am J Respir Crit Care Med, 2023, 207:1203-1213.
[24] Moufarrej MN, Vorperian SK, Wong RJ, et al. Early prediction of preeclampsia in pregnancy with cell-free RNA[J]. Nature, 2022, 602:689-694.
[25] Esfahani MS, Hamilton EG, Mehrmohamadi M, et al. Inferring gene expression from cell-free DNA fragmentation profiles[J]. Nat Biotechnol, 2022, 40:585-597.
Copyright (c) 2024 Tingting Zhao
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.